MALT LYMPHOMA
Clinical trials for MALT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MALT LYMPHOMA trials appear
Sign up with your email to follow new studies for MALT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to zap lymphoma with fewer side effects
Disease control Recruiting nowThis study tests a two-step treatment for adults with early-stage MALT lymphoma, a slow-growing cancer. First, patients get a very low dose of radiation over two days. Then, they take a daily pill called orelabrutinib for up to 6 months. The goal is to see if this approach can sh…
Matched conditions: MALT LYMPHOMA
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated May 26, 2026 15:31 UTC
-
New drug SGR-1505 enters early human testing for blood cancers
Disease control Recruiting nowThis early-phase study tests a new drug called SGR-1505 in about 98 adults with various B-cell blood cancers (like lymphoma and leukemia). The main goals are to check safety and find the best dose. Participants will receive the drug and be monitored for side effects and how the d…
Matched conditions: MALT LYMPHOMA
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated May 26, 2026 12:13 UTC